1-11 of 11
Primo N. Lara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Arian Lundberg, Meng Zhang, Rahul Aggarwal, Haolong Li, Li Zhang, Adam Foye, Martin Sjöström, Jonathan Chou, Kevin Chang, Thaidy Moreno-Rodriguez, Raunak Shrestha, Avi Baskin, Xiaolin Zhu, Alana S. Weinstein, Noah Younger, Joshi J. Alumkal, Tomasz M. Beer, Kim N. Chi, Christopher P. Evans, Martin Gleave, Primo N. Lara, Rob E. Reiter, Matthew B. Rettig, Owen N. Witte, Alexander W. Wyatt, Felix Y. Feng, Eric J. Small, David A. Quigley
Journal: Cancer Research
Cancer Res (2023) 83 (16): 2763–2774.
https://doi.org/10.1158/0008-5472.CAN-23-0593
Published: 15 August 2023
View article titled, The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Open the PDF for The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Arian Lundberg, Meng Zhang, Rahul R. Aggarwal, Haolong Li, Li Zhang, Adam Foye, Martin Sjöström, Jonathan Chou, Kevin Chang, Thaidy Moreno-Rodriguez, Raunak Shrestha, Avi Baskin, Xiaolin Zhu, Alana S. Weinstein, Noah Younger, Joshi J. Alumkal, Tomasz M. Beer, Kim N. Chi, Christopher P. Evans, Martin Gleave, Primo N. Lara, Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, Alexander W. Wyatt, Felix Y. Feng, Eric J. Small, David A. Quigley
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): B012.
https://doi.org/10.1158/1538-7445.PRCA2023-B012
Published: 02 June 2023
View article titled, Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer
Journal Articles

A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer

Xing Yi Woo, Anuj Srivastava, Philip C. Mack, Joel H. Graber, Brian J. Sanderson, Michael W. Lloyd, Mandy Chen, Sergii Domanskyi, Regina Gandour-Edwards, Rebekah A. Tsai, James Keck, Mingshan Cheng, Margaret Bundy, Emily L. Jocoy, Jonathan W. Riess, William Holland, Stephen C. Grubb, James G. Peterson, Grace A. Stafford, Carolyn Paisie, Steven B. Neuhauser, R. Krishna Murthy Karuturi, Joshy George, Allen K. Simons, Margaret Chavaree, Clifford G. Tepper, Neal Goodwin, Susan D. Airhart, Primo N. Lara, Jr, Thomas H. Openshaw, Edison T. Liu, David R. Gandara, Carol J. Bult
Journal: Cancer Research
Cancer Res (2022) 82 (22): 4126–4138.
https://doi.org/10.1158/0008-5472.CAN-22-0948
Published: 15 November 2022
View article titled, A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer
Open the PDF for A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Martin Sjöström, Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha, Arian Lundberg, Cameron Herberts, Adam Foye, Rahul Aggarwal, Junjie T. Hua, Haolong Li, Anna Bergamaschi, Corinne Maurice-Dror, Ashutosh Maheshwari, Sujun Chen, Sarah W.S. Ng, Wenbin Ye, Jessica Petricca, Michael Fraser, Lisa Chesner, Marc D. Perry, Thaidy Moreno-Rodriguez, William S. Chen, Joshi J. Alumkal, Jonathan Chou, Alicia K. Morgans, Tomasz M. Beer, George V. Thomas, Martin Gleave, Paul Lloyd, Tierney Phillips, Erin McCarthy, Michael C. Haffner, Amina Zoubeidi, Matti Annala, Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, Lawrence Fong, Rohit Bose, Franklin W. Huang, Jianhua Luo, Anders Bjartell, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phuoc T. Tran, Edwin M. Posadas, Chuan He, Xiao-Long Cui, Jiaoti Huang, Wilbert Zwart, Luke A. Gilbert, Christopher A. Maher, Paul C. Boutros, Kim N. Chi, Alan Ashworth, Eric J. Small, Housheng H. He, Alexander W. Wyatt, David A. Quigley, Felix Y. Feng
Journal: Cancer Research
Cancer Res (2022) 82 (21): 3888–3902.
https://doi.org/10.1158/0008-5472.CAN-22-1123
Published: 02 November 2022
View article titled, The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Open the PDF for The 5-Hydroxymethylcytosine Landscape of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3097: Patient-derived renal cell carcinoma xenografts engraftment identifies patients at risk of disease relapse, progression and death

Vilma Regina Martins, Adriano Beserra, Ethiene C. Estevan, Stephania Bezerra, Giovana T. Torrezan, Amanda Ikegani, Dellê Humberto, Isabela V. Cunha, Isabella T. Meira, Dirce M. Carraro, Primo N. Lara, Stenio Zequi, Tiago G. Santos
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3097.
https://doi.org/10.1158/1538-7445.AM2022-3097
Published: 15 June 2022
View article titled, Abstract 3097: Patient-derived renal cell carcinoma xenografts engraftment identifies patients at risk of disease relapse, progression and death
Journal Articles

Abstract 3827: NCI 8628 - A randomized phase II study of Ziv-aflibercept (Z) and high dose Interleukin-2 (IL-2) or IL-2 alone for inoperable stage III or IV melanoma

Ahmad A. Tarhini, Paul H. Frankel, Christopher Ruel, Marc S. Ernstoff, Timothy M. Kuzel, Theodore F. Logan, Nikhil I. Khushalani, Hussein A. Tawbi, Kim A. Margolin, Sanjay Awasthi, David F. McDermott, Alice Chen, Primo N. Lara, John M. Kirkwood
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3827.
https://doi.org/10.1158/1538-7445.AM2017-3827
Published: 01 July 2017
View article titled, Abstract 3827: NCI 8628 - A randomized phase II study of Ziv-aflibercept (Z) and high dose Interleukin-2 (IL-2) or IL-2 alone for inoperable stage III or IV melanoma
Journal Articles

Abstract 3394: CGP identifies largely non-overlapping high tumor mutational burden and HRD genomic alterations in 721 clinically advanced prostate acinar adenocarcinoma cases

Ninad Dewal, Yuting He, Richard J. Lee, Alexa B. Schrock, Jon Chung, Christopher Hoimes, Zachary R. Chalmers, Garrett M. Frampton, James X. Sun, Primo N. Lara, Neeraj Agrawal, Paul Matthew, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3394.
https://doi.org/10.1158/1538-7445.AM2017-3394
Published: 01 July 2017
View article titled, Abstract 3394: CGP identifies largely non-overlapping high tumor mutational burden and HRD genomic alterations in 721 clinically advanced prostate acinar adenocarcinoma cases
Journal Articles

Abstract 3522: A Phase 0 microdosing trial to identify chemoresistance: From bench to bedside

Sisi Wang, Miaoling He, Tao Li, Ralph de Vere White, Primo N. Lara, David Gandara, Philip C. Mack, Kenneth Turteltaub, Paul T. Henderson, Chong-xian Pan
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3522.
https://doi.org/10.1158/1538-7445.AM10-3522
Published: 15 April 2010
View article titled, Abstract 3522: A Phase 0 microdosing trial to identify chemoresistance: From bench to bedside
Journal Articles

Abstract 3720: Encouraging activity of bicalutamide and everolimus in castration-resistant prostate cancer (CRPC): Early results from a phase I/II clinical trial

Hongyong Zhang, Yu Wang, Paramita Ghosh, Primo N. Lara, Jr, Patricia Pasquinelli, Laurel Beckett, Ralph W. deVere White, Chong-Xian Pan
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3720.
https://doi.org/10.1158/1538-7445.AM10-3720
Published: 15 April 2010
View article titled, Abstract 3720: Encouraging activity of bicalutamide and everolimus in castration-resistant prostate cancer (CRPC): Early results from a phase I/II clinical trial
Journal Articles

Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer

Oliver Gautschi, Clifford G. Tepper, Phillip R. Purnell, Yoshihiro Izumiya, Christopher P. Evans, Tim P. Green, Pierre Y. Desprez, Primo N. Lara, David R. Gandara, Philip C. Mack, Hsing-Jien Kung
Journal: Cancer Research
Cancer Res (2008) 68 (7): 2250–2258.
https://doi.org/10.1158/0008-5472.CAN-07-6403
Published: 01 April 2008
View article titled, Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer
Open the PDF for Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer in another window
Includes: Supplementary data
Journal Articles

Plasma markers of tumor hypoxia-angiogenesis as predictors of therapeutic response

Philip C. Mack, Paul H. Gumerlock, Primo N. Lara, Jr., Quynh-Thu Le, Jeffrey A. Longmate, Kari Chansky, John J. Crowley, David R. Gandara
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 266.
Published: 01 May 2005
View article titled, Plasma markers of tumor hypoxia-angiogenesis as predictors of therapeutic response